Income Statement
BIOFRONTERA INC.
BFRI
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY |
|---|---|---|---|---|---|
|
Revenue
|
41.71 | 37.32 | 34.07 | 28.67 | 24.10 |
|
Cost of Revenue
|
0.85 | 0.75 | - | - | - |
|
Gross Profit
|
40.85 | 36.57 | 34.07 | 28.67 | 24.10 |
|
Operating Expenses
|
-7.44 | 35.88 | 56.75 | 47.26 | 49.30 |
|
Research & Development
|
3.72 | 2.09 | 0.08 | - | - |
|
Selling, General & Administrative
|
37.75 | 33.79 | 38.98 | 35.14 | 36.51 |
|
Other Operating Expenses
|
- | - | - | - | - |
|
Operating Income
|
-0.62 | 0.69 | -22.68 | -18.58 | -25.20 |
|
Non-Operating Income
|
0.84 | -0.53 | 2.56 | 17.97 | -12.46 |
|
Interest Income
|
- | 0.07 | 0.13 | 0.01 | 0.02 |
|
Interest Expense
|
0.40 | 0.30 | 0.22 | 0.20 | 0.34 |
|
Other Non-Op Income / Expense
|
0.39 | 0.16 | -0.08 | 0.03 | 0.69 |
|
Income Before Tax
|
-10.51 | -17.74 | -20.12 | -0.61 | -37.66 |
|
Income Tax Expense
|
0.03 | 0.02 | 0.01 | 0.03 | 0.06 |
|
Non-Controlling Interest
|
- | - | - | - | - |
|
Net Income
|
-10.54 | -17.76 | -20.13 | -0.64 | -37.71 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY |
|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - |
|
EBITDA
|
-0.48 | 0.69 | -22.68 | -18.58 | -25.20 |
|
Earnings Per Share (Basic)
|
-1.04 | -3.22 | -13.02 | -0.03 | - |
|
Diluted EPS
|
-1.04 | -3.22 | -13.02 | - | - |
|
Weighted Average Shares
|
10.17 | 5.52 | 1.55 | 21.14 | - |
|
Diluted Weighted Avg Shares
|
10.17 | 5.52 | 1.55 | - | - |
|
Comprehensive Income
|
- | - | - | - | - |